Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2007

Open Access 01-12-2007 | Original investigation

Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases

Authors: Stefano Brocco, Cristiana Visentin, Ugo Fedeli, Elena Schievano, Angelo Avogaro, Margherita Andretta, Francesco Avossa, Paolo Spolaore

Published in: Cardiovascular Diabetology | Issue 1/2007

Login to get access

Abstract

Objective

Diabetes mellitus is a growing public health problem, for which efficient and timely surveillance is a key policy. Administrative databases offer relevant opportunities for this purpose. We aim to monitor the incidence of diabetes and its major complications using administrative data.

Study design and methods

We study a population of about 850000 inhabitants in the Veneto Region (Italy) from the end of year 2001 to the end of year 2004. We use four administrative databases with record linkage. Databases of drug prescriptions and of exemptions from medical charge were linked to identify diabetic subjects; hospital discharge records and mortality data were used for the assessment of macrovascular and renal complications and vital status.

Results

We identified 30230 and 34620 diabetic subjects at the start and at the end of the study respectively. The row prevalence increased from 38.3/1000 (95% CI 37.2 – 39.5) to 43.2/1000 (95% CI 42.3 – 44) for males and from 34.7/1000 (95% CI 33.9 – 35.5) to 38.1/1000 (95% CI 37.4 – 39) for females. The mean row incidence is 5.3/1000 (95% CI 5 – 5.6) person years for males and 4.8/1000 (95% CI 4.4 – 5.2) person years for females. The rate of hospitalisations for cardiovascular or kidney diseases is greatly increased in diabetic people with respect to non diabetics for both genders. The mortality relative risk is particularly important in younger age classes: diabetic males and females aged 45–64 years present relative risk for death of 1.7 (95% CI 1.58 – 1.88) and 2.6 (95% CI 2.29 – 2.97) respectively.

Conclusion

This study provides a feasible and efficient method to determine and monitor the incidence and prevalence of diabetes and the occurrence of its complications along with indexes of morbidity and mortality.
Appendix
Available only for authorised users
Literature
1.
go back to reference King H, Aubert RE, Herman WH: Global Burden of diabetes, 1995–2025. Diabetes Care. 1998, 21: 1414-1431.CrossRefPubMed King H, Aubert RE, Herman WH: Global Burden of diabetes, 1995–2025. Diabetes Care. 1998, 21: 1414-1431.CrossRefPubMed
2.
go back to reference Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM: The evolving diabetes burden in the United States. Ann Intern Med. 2004, 140: 945-950.CrossRefPubMed Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM: The evolving diabetes burden in the United States. Ann Intern Med. 2004, 140: 945-950.CrossRefPubMed
3.
go back to reference Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J: Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000, 23: 1516-1526.CrossRefPubMed Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J: Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care. 2000, 23: 1516-1526.CrossRefPubMed
4.
go back to reference Lipman TH, Chang Y, Murphy KM: The epidemiology of type 1 diabetes in children in Philadelphia 1990–1994: evidence of an epidemic. Diabetes Care. 2002, 25: 1969-1975.CrossRefPubMed Lipman TH, Chang Y, Murphy KM: The epidemiology of type 1 diabetes in children in Philadelphia 1990–1994: evidence of an epidemic. Diabetes Care. 2002, 25: 1969-1975.CrossRefPubMed
5.
6.
go back to reference James RC, Blanchard JF, Campbell D, Clottey C, Osei W, Svenson LW, Noseworthy TW: A model for non-communicable disease surveillance in Canada: The Prairie Pilot Diabetes Surveillance System. Chronic Dis Can. 2004, 25: 7-12. WinterPubMed James RC, Blanchard JF, Campbell D, Clottey C, Osei W, Svenson LW, Noseworthy TW: A model for non-communicable disease surveillance in Canada: The Prairie Pilot Diabetes Surveillance System. Chronic Dis Can. 2004, 25: 7-12. WinterPubMed
7.
go back to reference Morgan CL, Currie CJ, Peters JR: Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care. 2000, 23: 1103-1107.CrossRefPubMed Morgan CL, Currie CJ, Peters JR: Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care. 2000, 23: 1103-1107.CrossRefPubMed
8.
go back to reference Maio V, Yuen E, Rabinowitz C, Louis D, Jimbo M, Donatini A, Mall S, Taroni F: Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy. 2005, 10: 232-238. 10.1258/135581905774414259.CrossRefPubMed Maio V, Yuen E, Rabinowitz C, Louis D, Jimbo M, Donatini A, Mall S, Taroni F: Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy. J Health Serv Res Policy. 2005, 10: 232-238. 10.1258/135581905774414259.CrossRefPubMed
9.
go back to reference Desai J, Geiss L, Mukhtar Q, Harwell T, Benjamin S, Bell R, Tierney E: Public health surveillance of diabetes in the United States. J Public Health Manag Pract. 2003, S44-51. Suppl Desai J, Geiss L, Mukhtar Q, Harwell T, Benjamin S, Bell R, Tierney E: Public health surveillance of diabetes in the United States. J Public Health Manag Pract. 2003, S44-51. Suppl
10.
go back to reference Bo S, Ciccone G, Grassi G, Gancia R, Rosato R, Merletti F, Pagano GF: Patients with type 2 diabetes had higher rates of hospitalisation than the general population. J Clin Epid. 2004, 57: 1196-1201. 10.1016/j.jclinepi.2004.02.015.CrossRef Bo S, Ciccone G, Grassi G, Gancia R, Rosato R, Merletti F, Pagano GF: Patients with type 2 diabetes had higher rates of hospitalisation than the general population. J Clin Epid. 2004, 57: 1196-1201. 10.1016/j.jclinepi.2004.02.015.CrossRef
11.
go back to reference Gambassi G, Landi F, Peng L, Brostrup-Jensen C, Calore K, Hiris J, Lipsitz L, Mor V, Bernabei R: Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care. 1998, 36: 167-179. 10.1097/00005650-199802000-00006.CrossRefPubMed Gambassi G, Landi F, Peng L, Brostrup-Jensen C, Calore K, Hiris J, Lipsitz L, Mor V, Bernabei R: Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. Med Care. 1998, 36: 167-179. 10.1097/00005650-199802000-00006.CrossRefPubMed
12.
go back to reference O'Connor PJ, Rush WA, Pronk NP, Cherney LM: Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care. 1998, 4: 335-342.PubMed O'Connor PJ, Rush WA, Pronk NP, Cherney LM: Identifying diabetes mellitus or heart disease among health maintenance organization members: sensitivity, specificity, predictive value, and cost of survey and database methods. Am J Manag Care. 1998, 4: 335-342.PubMed
13.
go back to reference Saydah SH, Geiss LS, Tierney E, Benjamin SM, Engelgau M, Brancati F: Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol. 2004, 14: 507-16. 10.1016/j.annepidem.2003.09.016.CrossRefPubMed Saydah SH, Geiss LS, Tierney E, Benjamin SM, Engelgau M, Brancati F: Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Ann Epidemiol. 2004, 14: 507-16. 10.1016/j.annepidem.2003.09.016.CrossRefPubMed
14.
go back to reference Rothman KJ, Greenland S: Modern epidemiology. 1998, Lippincott Williams & Wilkins Eds. Philadelphia, PA, second Rothman KJ, Greenland S: Modern epidemiology. 1998, Lippincott Williams & Wilkins Eds. Philadelphia, PA, second
15.
go back to reference Gnavi R, Karaghiosoff L, Dalmasso M, Bruno G: The Piedmont Diabetes Register: opportunities and limits for epidemiological purposes. Epidemiol Prev. 2006, 30: 59-64. ItalianPubMed Gnavi R, Karaghiosoff L, Dalmasso M, Bruno G: The Piedmont Diabetes Register: opportunities and limits for epidemiological purposes. Epidemiol Prev. 2006, 30: 59-64. ItalianPubMed
16.
go back to reference Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M: Population-based incidence rates and risk factors for type 2 diabetes in white individuals. Diabetes. 2004, 53: 1782-1789.CrossRefPubMed Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M: Population-based incidence rates and risk factors for type 2 diabetes in white individuals. Diabetes. 2004, 53: 1782-1789.CrossRefPubMed
17.
go back to reference Bruno G, Runzo C, Cavallo-Perin P, Merletti F, Rivetti M, Pinach S, Novelli G, Trovati M, Cerutti F, Pagano G, for the Piedmont study group for diabetes epidemiology: Incidence of type 1 and type 2 diabetes in adults aged 30–49 years. Diabetes Care. 2005, 28: 2613-9.CrossRefPubMed Bruno G, Runzo C, Cavallo-Perin P, Merletti F, Rivetti M, Pinach S, Novelli G, Trovati M, Cerutti F, Pagano G, for the Piedmont study group for diabetes epidemiology: Incidence of type 1 and type 2 diabetes in adults aged 30–49 years. Diabetes Care. 2005, 28: 2613-9.CrossRefPubMed
18.
go back to reference Fleming DM, Schellevis FG, Van Casteren V: The prevalence of known diabetes in eight European countries. Eur J Public Health. 2004, 14: 10-14. 10.1093/eurpub/14.1.10.CrossRefPubMed Fleming DM, Schellevis FG, Van Casteren V: The prevalence of known diabetes in eight European countries. Eur J Public Health. 2004, 14: 10-14. 10.1093/eurpub/14.1.10.CrossRefPubMed
19.
go back to reference Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Bird_holt DD: Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. adults. Diabetes Care. 1998, 21: 518-524.CrossRefPubMed Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Bird_holt DD: Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in U.S. adults. Diabetes Care. 1998, 21: 518-524.CrossRefPubMed
20.
go back to reference DAI study group: The prevalence of coronary heart disease in Type 2 diabetic patients in Italy: the DAI study. Diabet Med. 2004, 21: 738-745. 10.1111/j.1464-5491.2004.01230.x.CrossRef DAI study group: The prevalence of coronary heart disease in Type 2 diabetic patients in Italy: the DAI study. Diabet Med. 2004, 21: 738-745. 10.1111/j.1464-5491.2004.01230.x.CrossRef
21.
go back to reference Donnan PT, Morris AD, Leese GP, for the DARTS/DEMO collaboration: Hospitalizations for people with type 1 and type 2 diabetes compared with the non diabetic population of Tayside, Scotland. Diabetes Care. 2000, 23: 1774-1779.CrossRefPubMed Donnan PT, Morris AD, Leese GP, for the DARTS/DEMO collaboration: Hospitalizations for people with type 1 and type 2 diabetes compared with the non diabetic population of Tayside, Scotland. Diabetes Care. 2000, 23: 1774-1779.CrossRefPubMed
22.
go back to reference Booth GL, Kapral MK, Fung K, Tu JV: Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care. 2006, 29: 32-37. 10.2337/diacare.29.01.06.dc05-0776.CrossRefPubMed Booth GL, Kapral MK, Fung K, Tu JV: Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care. 2006, 29: 32-37. 10.2337/diacare.29.01.06.dc05-0776.CrossRefPubMed
23.
go back to reference Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M: The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003, 56: 124-130. 10.1016/S0895-4356(02)00591-7.CrossRefPubMed Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M: The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003, 56: 124-130. 10.1016/S0895-4356(02)00591-7.CrossRefPubMed
24.
go back to reference Spolaore P, Brocco S, Fedeli U, Visentin C, Schievano E, Avossa F, Milan G, Toso V, Vanuzzo D, Pilotto L, Pessina AC, Bonita R: Measuring accuracy of discharge diagnoses for a region-wide surveillance of hospitalized strokes. Stroke. 2005, 36: 1031-1034. 10.1161/01.STR.0000160755.94884.4a.CrossRefPubMed Spolaore P, Brocco S, Fedeli U, Visentin C, Schievano E, Avossa F, Milan G, Toso V, Vanuzzo D, Pilotto L, Pessina AC, Bonita R: Measuring accuracy of discharge diagnoses for a region-wide surveillance of hospitalized strokes. Stroke. 2005, 36: 1031-1034. 10.1161/01.STR.0000160755.94884.4a.CrossRefPubMed
26.
go back to reference Nielson C, Lange T: Blood glucose and heart failure in non diabetic patients. Diabetes Care. 2005, 28: 607-611.CrossRefPubMed Nielson C, Lange T: Blood glucose and heart failure in non diabetic patients. Diabetes Care. 2005, 28: 607-611.CrossRefPubMed
Metadata
Title
Monitoring the occurrence of diabetes mellitus and its major complications: the combined use of different administrative databases
Authors
Stefano Brocco
Cristiana Visentin
Ugo Fedeli
Elena Schievano
Angelo Avogaro
Margherita Andretta
Francesco Avossa
Paolo Spolaore
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2007
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-6-5

Other articles of this Issue 1/2007

Cardiovascular Diabetology 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.